UniProt ID | KAP1_HUMAN | |
---|---|---|
UniProt AC | P31321 | |
Protein Name | cAMP-dependent protein kinase type I-beta regulatory subunit | |
Gene Name | PRKAR1B | |
Organism | Homo sapiens (Human). | |
Sequence Length | 381 | |
Subcellular Localization | Cell membrane . | |
Protein Description | Regulatory subunit of the cAMP-dependent protein kinases involved in cAMP signaling in cells.. | |
Protein Sequence | MASPPACPSEEDESLKGCELYVQLHGIQQVLKDCIVHLCISKPERPMKFLREHFEKLEKEENRQILARQKSNSQSDSHDEEVSPTPPNPVVKARRRRGGVSAEVYTEEDAVSYVRKVIPKDYKTMTALAKAISKNVLFAHLDDNERSDIFDAMFPVTHIAGETVIQQGNEGDNFYVVDQGEVDVYVNGEWVTNISEGGSFGELALIYGTPRAATVKAKTDLKLWGIDRDSYRRILMGSTLRKRKMYEEFLSKVSILESLEKWERLTVADALEPVQFEDGEKIVVQGEPGDDFYIITEGTASVLQRRSPNEEYVEVGRLGPSDYFGEIALLLNRPRAATVVARGPLKCVKLDRPRFERVLGPCSEILKRNIQRYNSFISLTV | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
3 | Phosphorylation | -----MASPPACPSE -----CCCCCCCCCC | 30.07 | 29255136 | |
9 | Phosphorylation | ASPPACPSEEDESLK CCCCCCCCCCCCCCC | 54.20 | 20044836 | |
14 | Phosphorylation | CPSEEDESLKGCELY CCCCCCCCCCCCCEE | 47.94 | 25159151 | |
21 | Nitrated tyrosine | SLKGCELYVQLHGIQ CCCCCCEEHHHCCHH | 2.38 | - | |
21 | Nitration | SLKGCELYVQLHGIQ CCCCCCEEHHHCCHH | 2.38 | 16777052 | |
21 | Nitration | SLKGCELYVQLHGIQ CCCCCCEEHHHCCHH | 2.38 | 16777052 | |
37 | Ubiquitination | VLKDCIVHLCISKPE HHHHHHHHHHCCCCC | 8.62 | 21963094 | |
71 | Phosphorylation | QILARQKSNSQSDSH HHHHHHHCCCCCCCC | 33.12 | 25159151 | |
73 | Phosphorylation | LARQKSNSQSDSHDE HHHHHCCCCCCCCCC | 37.85 | 23401153 | |
75 | Phosphorylation | RQKSNSQSDSHDEEV HHHCCCCCCCCCCCC | 40.68 | 29255136 | |
77 | Phosphorylation | KSNSQSDSHDEEVSP HCCCCCCCCCCCCCC | 37.78 | 29255136 | |
83 | Phosphorylation | DSHDEEVSPTPPNPV CCCCCCCCCCCCCHH | 26.74 | 29255136 | |
85 | Phosphorylation | HDEEVSPTPPNPVVK CCCCCCCCCCCHHHH | 43.82 | 29255136 | |
90 | Ubiquitination | SPTPPNPVVKARRRR CCCCCCHHHHHHHHC | 9.79 | 22817900 | |
92 | Ubiquitination | TPPNPVVKARRRRGG CCCCHHHHHHHHCCC | 36.09 | 27667366 | |
97 | Methylation | VVKARRRRGGVSAEV HHHHHHHCCCCCEEE | 44.39 | - | |
100 | Ubiquitination | ARRRRGGVSAEVYTE HHHHCCCCCEEEECH | 5.66 | 22817900 | |
109 | Ubiquitination | AEVYTEEDAVSYVRK EEEECHHHHHHHHHH | 46.14 | 21890473 | |
112 | Ubiquitination | YTEEDAVSYVRKVIP ECHHHHHHHHHHHCC | 21.45 | 22817900 | |
114 | Ubiquitination | EEDAVSYVRKVIPKD HHHHHHHHHHHCCCC | 3.58 | 21890473 | |
122 | Ubiquitination | RKVIPKDYKTMTALA HHHCCCCHHHHHHHH | 17.93 | 22817900 | |
131 | Ubiquitination | TMTALAKAISKNVLF HHHHHHHHHHHCCEE | 12.99 | 21890473 | |
187 | Ubiquitination | GEVDVYVNGEWVTNI CEEEEEECCEEEEEE | 25.61 | 22817900 | |
189 | Ubiquitination | VDVYVNGEWVTNISE EEEEECCEEEEEECC | 33.30 | 21890473 | |
194 | Ubiquitination | NGEWVTNISEGGSFG CCEEEEEECCCCCHH | 2.64 | 23000965 | |
197 | Ubiquitination | WVTNISEGGSFGELA EEEEECCCCCHHHEE | 30.19 | 23000965 | |
206 | Ubiquitination | SFGELALIYGTPRAA CHHHEEEEECCCCCC | 2.19 | 21890473 | |
207 | Phosphorylation | FGELALIYGTPRAAT HHHEEEEECCCCCCE | 18.79 | - | |
209 | Phosphorylation | ELALIYGTPRAATVK HEEEEECCCCCCEEE | 7.82 | 16582606 | |
215 | Ubiquitination | GTPRAATVKAKTDLK CCCCCCEEEECCCCE | 4.94 | 24816145 | |
216 | Ubiquitination | TPRAATVKAKTDLKL CCCCCEEEECCCCEE | 39.55 | 23000965 | |
219 | Ubiquitination | AATVKAKTDLKLWGI CCEEEECCCCEECCC | 51.96 | 23000965 | |
222 | Ubiquitination | VKAKTDLKLWGIDRD EEECCCCEECCCCHH | 45.03 | 33845483 | |
237 | Ubiquitination | SYRRILMGSTLRKRK HHHHHHCCHHHHHHH | 17.65 | 24816145 | |
238 | Phosphorylation | YRRILMGSTLRKRKM HHHHHCCHHHHHHHH | 15.42 | 30108239 | |
239 | Phosphorylation | RRILMGSTLRKRKMY HHHHCCHHHHHHHHH | 25.50 | 23403867 | |
242 | Ubiquitination | LMGSTLRKRKMYEEF HCCHHHHHHHHHHHH | 60.53 | 22817900 | |
244 | Ubiquitination | GSTLRKRKMYEEFLS CHHHHHHHHHHHHHH | 49.20 | 21906983 | |
246 | Phosphorylation | TLRKRKMYEEFLSKV HHHHHHHHHHHHHHH | 18.49 | - | |
251 | Phosphorylation | KMYEEFLSKVSILES HHHHHHHHHHHHHHH | 36.01 | 25850435 | |
252 | Ubiquitination | MYEEFLSKVSILESL HHHHHHHHHHHHHHH | 41.99 | 22817900 | |
254 | Phosphorylation | EEFLSKVSILESLEK HHHHHHHHHHHHHHH | 25.78 | 20068231 | |
258 | Phosphorylation | SKVSILESLEKWERL HHHHHHHHHHHHHCC | 38.08 | 20068231 | |
261 | Ubiquitination | SILESLEKWERLTVA HHHHHHHHHHCCCHH | 60.70 | 21963094 | |
291 | Ubiquitination | VQGEPGDDFYIITEG ECCCCCCCEEEEEEC | 44.13 | 23000965 | |
294 | Ubiquitination | EPGDDFYIITEGTAS CCCCCEEEEEECCHH | 2.95 | 23000965 | |
307 | Phosphorylation | ASVLQRRSPNEEYVE HHHHCCCCCCCCCEE | 33.98 | 27642862 | |
312 | Ubiquitination | RRSPNEEYVEVGRLG CCCCCCCCEEECCCC | 8.84 | 24816145 | |
312 | Phosphorylation | RRSPNEEYVEVGRLG CCCCCCCCEEECCCC | 8.84 | 24927040 | |
323 | Phosphorylation | GRLGPSDYFGEIALL CCCCCCCCHHHHHHH | 20.16 | - | |
338 | Phosphorylation | LNRPRAATVVARGPL HCCCCCEEEEECCCE | 17.96 | 23312004 | |
342 | Methylation | RAATVVARGPLKCVK CCEEEEECCCEEEEE | 35.34 | - | |
346 | Ubiquitination | VVARGPLKCVKLDRP EEECCCEEEEECCCH | 39.86 | 23000965 | |
349 | Ubiquitination | RGPLKCVKLDRPRFE CCCEEEEECCCHHHH | 54.89 | 23000965 | |
367 | Ubiquitination | GPCSEILKRNIQRYN HHHHHHHHHHHHHHH | 49.40 | 24816145 | |
373 | Phosphorylation | LKRNIQRYNSFISLT HHHHHHHHHCCEEEE | 9.97 | 30257219 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of KAP1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of KAP1_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
AKAP1_HUMAN | AKAP1 | physical | 12634056 | |
KAP1_HUMAN | PRKAR1B | physical | 12634056 | |
KAP0_HUMAN | PRKAR1A | physical | 12634056 | |
THG1_HUMAN | THG1L | physical | 22863883 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Nitration | |
Reference | PubMed |
"Nitroproteins from a human pituitary adenoma tissue discovered with anitrotyrosine affinity column and tandem mass spectrometry."; Zhan X., Desiderio D.M.; Anal. Biochem. 354:279-289(2006). Cited for: NITRATION [LARGE SCALE ANALYSIS] AT TYR-21, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-83, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-77 AND SER-83, AND MASSSPECTROMETRY. | |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-3 AND SER-83, AND MASSSPECTROMETRY. |